The appointed executive came from a fast-growing European SaaS provider in the real-world data and research analytics space. Within twelve months, they built a structured partner program, introduced a formal sales methodology, and secured three major enterprise agreements with top-tier pharma and CRO clients. The business achieved €4M in new annual recurring revenue and expanded operations into two new regions, giving the company the commercial foundation it needed to scale internationally.